Intralymphatic Cutaneous Anaplastic Large Cell Lymphoma/Lymphomatoid Papulosis
Authors:
- Albert SuASAlbert Su
- Seong RaSRSeong Ra
- Mark A. CappelMCMark A. Cappel
- Abner LouissantALAbner Louissant
- Ryan A. KnudsonRKRyan A. Knudson
- Rhett P. KetterlingRKRhett P. Ketterling
- Jonathan SaidJSJonathan Said
- Scott BinderSBScott Binder
- Nancy Lee HarrisNHNancy Lee Harris
- Andrew L. FeldmanAFAndrew L. Feldman
- Jinah KimJKJinah Kim
- 1 September 2014
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 38 (9) , 1203-1211
Abstract
Intravascular large B-cell lymphomas and EBV NK/T-cell lymphomas commonly follow an aggressive clinical course. We recently reported an entirely intravascular anaplastic large cell lymphoma (ALCL) in the skin with a surprisingly indolent clinical course; interestingly, this lymphoma involved the lymphatic rather than the blood vasculature. We hypothesized that intravascular skin-limited ALCL is distinct from aggressive systemic intravascular lymphomas in its intralymphatic localization and clinical course. We now describe 18 cases of cutaneous intravascular large cell lymphoproliferations from 4 institutions. All 12 intravascular large T-cell lesions were intralymphatic; the majority (9) were CD30 T-cell lymphoproliferative disorders (TLPDs), 5 further classified as intravascular ALK ALCL. One ALK ALCL and 2 benign microscopic intravascular T-cell proliferations were also intralymphatic. A single case of otherwise typical cutaneous follicle center lymphoma contained intralymphatic centroblasts. The clinical and pathologic characteristics of the CD30 TLPDs were similar to those of their extravascular counterparts, including extralymphatic dermal involvement in a subset, DUSP22-IRF4 translocations in half of tested ALK ALCLs, and associated mycosis fungoides in 1; most were skin-limited at baseline and remained so at relapse. All 5 cases of intravascular large B-cell lymphoma involved the blood vasculature and behaved in a clinically aggressive manner; the ALK ALCL, although intralymphatic, was systemic and clinically aggressive. We propose that cutaneous ALK ALCL and related CD30 ALK TLPDs involving the lymphatics are part of an expanding spectrum of CD30 TLPDs. The identification of intralymphatic as distinct from blood vascular localization may provide critical prognostic and therapeutic information.Keywords
This publication has 30 references indexed in Scilit:
- Intravascular ALK-negative Anaplastic Large Cell Lymphoma With Localized Cutaneous Involvement and an Indolent Clinical CourseAmerican Journal of Surgical Pathology, 2013
- Cutaneous Intravascular Anaplastic Large T-Cell LymphomaThe American Journal of Dermatopathology, 2012
- Cutaneous CD30‐positive lymphoproliferative disorders with CD8 expression: a clinicopathologic study of 21 casesJournal of Cutaneous Pathology, 2012
- EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma*Blood, 2011
- Intravascular Large B-Cell Lymphoma: A Mimicker of Many Maladies and a Difficult and Often Delayed DiagnosisJournal of Clinical Oncology, 2011
- Cutaneous intravascular anaplastic large cell lymphomaJournal of Cutaneous Pathology, 2010
- ALK-negative systemic intravascular anaplastic large cell lymphoma presenting in the skinJournal of Cutaneous Pathology, 2010
- ALK− anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma ProjectBlood, 2008
- Skin manifestations of intravascular lymphoma mimic inflammatory diseases of the skinBritish Journal of Dermatology, 2007
- Cutaneous Intravascular NK-cell Lymphoma: Report of a Rare Variant Associated With Epstein-Barr VirusAmerican Journal of Surgical Pathology, 2006